I now have all the content I need from Harrison's. Let me compile the comprehensive, easy-to-understand response.
Chronic Diarrhea: Consultant Approach
Reference: Harrison's Principles of Internal Medicine, 22nd Edition (2025)
1. Definition
Diarrhea lasting >4 weeks warrants evaluation to exclude serious underlying pathology. Unlike acute diarrhea, most causes of chronic diarrhea are non-infectious. Classification by pathophysiologic mechanism gives a rational framework for management.
Harrison's, p. 350
2. Pathophysiologic Classification (The "WHY" of Diarrhea)
Harrison's organizes chronic diarrhea into 6 mechanism-based categories. Think of this as your core mental model:
A. Secretory Diarrhea
Key feature: Watery, large-volume, persists with fasting, no osmotic gap in stool.
The gut is actively secreting too much fluid - or not absorbing enough - due to a derangement in electrolyte transport.
| Cause | Examples |
|---|
| Medications/toxins | Stimulant laxatives (senna, bisacodyl), ethanol, arsenic, olmesartan (sprue-like), GLP-1 agonists (semaglutide) |
| Bowel resection/fistula | Short bowel; worsens with eating (unlike other secretory causes) |
| Bile acid diarrhea (BAD) | Accounts for ~40% of unexplained chronic diarrhea; ileal dysfunction/resection <100 cm |
| Hormone-secreting tumors | Carcinoid (serotonin, VIP), VIPoma ("pancreatic cholera" - stool up to 20 L/d), Gastrinoma, Medullary thyroid cancer |
| Addison's disease | Mineralocorticoid deficiency |
Harrison's, pp. 350-352
B. Osmotic Diarrhea
Key feature: Watery, stops with fasting, elevated fecal osmotic gap (>50 mOsm/kg).
Unabsorbed solutes drag water into the gut lumen.
| Cause | Examples |
|---|
| Osmotic laxatives | Mg²⁺, phosphate, sulfate (antacids, bowel preps) |
| Disaccharide deficiency | Lactase deficiency (most common) |
| Non-absorbable carbohydrates | Fructose, sorbitol, lactulose, polyethylene glycol, FODMAPs |
Harrison's, p. 350
C. Steatorrheal (Fatty) Diarrhea
Key feature: Bulky, greasy, foul-smelling stool; weight loss; fat-soluble vitamin deficiency (A, D, E, K).
Three sub-levels of fat malabsorption:
| Level | Mechanism | Causes |
|---|
| Intraluminal maldigestion | Not enough digestive enzymes or bile | Chronic pancreatitis, pancreatic cancer, bile salt deficiency |
| Mucosal malabsorption | Damaged absorptive surface | Celiac disease, Whipple's disease, infections, drug-induced enteropathy |
| Post-mucosal obstruction | Lymphatic blockage | Primary/secondary lymphatic obstruction, amyloidosis |
Harrison's, p. 350
D. Inflammatory Diarrhea
Key feature: Blood or leukocytes in stool, fever, abdominal pain, elevated CRP/ESR.
Mucosal damage disrupts both absorption and barrier function.
| Cause |
|---|
| Idiopathic IBD (Crohn's disease, ulcerative colitis) |
| Microscopic colitis (lymphocytic & collagenous) |
| Immune-mediated (food allergy, eosinophilic gastroenteritis, graft-vs-host disease) |
| Infections (invasive bacteria, viruses, parasites) |
| Radiation injury |
| GI malignancies |
Harrison's, p. 350
E. Dysmotility Diarrhea
Key feature: Associated with abdominal cramping, bloating, urgency; often IBS pattern.
Too-rapid transit = less time for absorption.
| Cause |
|---|
| IBS (including post-infectious IBS) |
| Visceral neuropathies |
| Hyperthyroidism |
| Prokinetic drugs |
| Post-vagotomy |
Harrison's, p. 350
F. Factitial / Iatrogenic Causes
| Category | Examples |
|---|
| Factitial | Munchausen syndrome, eating disorders (laxative abuse) |
| Iatrogenic | Cholecystectomy, ileal resection, bariatric surgery, vagotomy, fundoplication |
Harrison's, p. 350
3. Diagnostic Approach (The "HOW" to Evaluate)
The key principle from Harrison's: "The diagnostic evaluation must be rationally directed by a careful history, including medications, and physical examination."
Step 1: History - Key Questions to Ask
- Onset and duration - exactly when did it start?
- Pattern - constant vs. intermittent, nocturnal episodes (organic > functional)?
- Stool character - watery, fatty, bloody? Bristol Stool Scale
- Volume - large vs. small-volume stools
- Aggravating factors - does it stop with fasting? (osmotic) or persist? (secretory)
- Dietary associations - dairy, wheat, sorbitol-containing foods, FODMAPs
- Travel history - backpacking, tropical regions (think Giardia)
- Medications - every drug, including OTC, supplements, laxatives
- Weight loss, fever, arthralgia, skin changes - alarm/organic features
- Family history - IBD, celiac disease
- Prior surgery - cholecystectomy, ileal resection, bariatric
Harrison's, p. 354
Step 2: Physical Examination - What to Look For
| Finding | Suggests |
|---|
| Anemia, edema, clubbing, dermatitis herpetiformis | Malabsorption, IBD |
| Thyroid mass, wheezing, heart murmur, flushing | Carcinoid, hyperthyroidism |
| Orthostasis, pupil abnormalities | Autonomic neuropathy (DM) |
| Abdominal mass or tenderness | Neoplasia, IBD |
| Perianal fistulas, anal sphincter laxity | Crohn's disease, fecal incontinence |
| Oral aphthous ulcers | IBD, celiac disease |
| Erythema nodosum | Ulcerative colitis |
| Lymphadenopathy | Lymphoma, Whipple's |
Harrison's, p. 354
Step 3: Initial Laboratory Screen
"Limited screen for organic disease" (from the algorithm):
- Hematology: CBC (Hb, MCV, MCH) - anemia suggests malabsorption/IBD
- Chemistry: Albumin (low = malabsorption/inflammation), electrolytes (hypokalemia in secretory), LFTs
- Inflammatory markers: CRP, ESR
- Nutritional screen: Iron, folate, B12
- Celiac screen: TTG-IgA
- Stool: Fecal calprotectin (inflammation), occult blood
- 7αC4 or serum C4 (bile acid marker): Elevated in bile acid diarrhea
Harrison's, p. 354 - Fig. 49-4
Step 4: Diagnostic Algorithm - The Branching Logic
The Harrison's algorithm (Fig. 49-4) branches based on the dominant stool character:
Figure 49-4 from Harrison's - Algorithm for management of chronic diarrhea
Branch 1: Blood per rectum
→ Colonoscopy + biopsy (rule out IBD, malignancy, microscopic colitis)
Branch 2: Fatty diarrhea (steatorrhea)
→ Small bowel: imaging, biopsy, aspirate
- Stool fat >20 g/day → evaluate pancreatic function (exocrine insufficiency)
- Stool fat 14-20 g/day → search for small bowel mucosal cause
- Stool fat <14 g/day → normal range
Branch 3: Pain before BM, relieved with BM, incomplete evacuation
→ Suspect IBS → sigmoidoscopy with biopsies to exclude microscopic colitis
Branch 4: No blood, no malabsorption features
→ Consider functional diarrhea → dietary exclusion (lactose, sorbitol)
When screening tests are abnormal:
- Low Hb/Alb + abnormal MCV/MCH + excess fat in stool → Colonoscopy + biopsy AND small bowel x-ray/biopsy
- Low serum K⁺ → Stool volume, osmolality, pH; laxative screen; hormonal screen (gastrin, VIP, calcitonin, TSH, urinary 5-HIAA, histamine)
- All normal → Empirical opioid (loperamide) + follow-up; if persistent → gut transit test + 48h stool bile acid
Step 5: Targeted Investigation Based on Suspected Mechanism
Secretory diarrhea (normal osmotic gap):
- Stool microbiologic studies (multiplex PCR panel, cultures, ova & parasites, Giardia antigen)
- Breath tests for SIBO (glucose/lactulose - H₂/CH₄)
- Upper endoscopy + colonoscopy with biopsies
- Small bowel imaging (CT enterography or MR enteroclysis)
- Hormonal screens: gastrin, VIP, calcitonin, TSH, urinary 5-HIAA, histamine
Osmotic diarrhea (elevated osmotic gap):
- Lactose breath test or therapeutic trial of lactose exclusion
- Fructose tolerance test
- Fecal Mg²⁺ level (check surreptitious laxative use)
- Stool pH <5.6 suggests carbohydrate malabsorption
Steatorrheal diarrhea:
- Endoscopy + small-bowel biopsy with aspirate for cultures
- Pancreatic function tests (if small bowel unrevealing)
- CT/MRI abdomen for pancreatic pathology
Inflammatory diarrhea:
- Stool pathogen testing
- Colonoscopy with biopsies
- Small bowel imaging
Harrison's, pp. 354-355
4. Treatment
Treatment depends on the etiology - curative, suppressive, or empirical.
| Goal | Examples |
|---|
| Curative | Resect colorectal cancer; antibiotics for Whipple's/tropical sprue; stop offending drug |
| Suppressive (mechanism-targeted) | |
| - Lactase deficiency | Lactose-restricted diet |
| - Celiac disease | Gluten-free diet |
| - IBD | Anti-inflammatory agents (mesalamine, steroids, biologics) |
| - Bile acid malabsorption | Bile acid sequestrants (cholestyramine, colestipol, colesevelam) |
| - Gastrinoma | Proton pump inhibitors |
| - Carcinoid syndrome | Octreotide (somatostatin analogue) |
| - Medullary thyroid cancer | Indomethacin (prostaglandin inhibitor) |
| - Pancreatic insufficiency | Pancreatic enzyme replacement |
| Empirical (when cause unknown) | |
| - Mild-moderate watery | Loperamide or diphenoxylate |
| - Severe | Codeine or tincture of opium (avoid in severe IBD - risk of toxic megacolon) |
| - Diabetic diarrhea | Clonidine (α₂-agonist) - skin patch preferred (less orthostasis) |
| - IBS-D | 5-HT3 antagonists (alosetron, ondansetron); Rifaximin; Eluxadoline* |
| - AIDS-associated diarrhea | Crofelemer (antisecretory) |
⚠️ Eluxadoline is contraindicated or risky in patients post-cholecystectomy (sphincter of Oddi spasm → acute pancreatitis)
Always: Fluid and electrolyte repletion + fat-soluble vitamin replacement if steatorrhea present.
Harrison's, p. 355
Summary: The Consultant's Mental Checklist
Chronic diarrhea (>4 weeks)
│
├── 1. HISTORY → mechanism clue + alarm features
├── 2. EXAMINATION → systemic signs
├── 3. BASIC LABS + STOOL SCREEN
├── 4. BRANCH by stool type:
│ Blood → colonoscopy
│ Fatty → small bowel workup
│ IBS pattern → sigmoidoscopy/biopsy
│ Functional pattern → dietary exclusion
├── 5. IF STILL UNCLEAR → quantitative stool analysis
│ Osmotic gap → osmotic/secretory distinction
│ Stool fat → steatorrheal workup
│ Hormonal screen → if secretory + low K⁺
└── 6. TREAT based on mechanism identified
Reference: Harrison's Principles of Internal Medicine, 22nd Edition (2025, McGraw Hill Medical), Chapter 49 - Diarrhea and Constipation, pp. 350-355.